Back to PFE Stock Lookup
Pages: 1 2 »» Last Page

Pfizer (PFE) – Press Releases

Aug 3, 2015 08:30 AM Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Jul 29, 2015 07:30 AM Hospira Reports Second-Quarter 2015 Results
Jul 28, 2015 07:00 AM PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
Jul 22, 2015 08:30 AM Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility
Jul 21, 2015 08:00 AM America's Most-Preferred Bone Health Brand Launches New Caltrate® Bone & Joint Health Supplement
Jul 8, 2015 08:30 AM Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research
Jul 8, 2015 08:00 AM Nodality, Inc. Appoints Kathleen LaPorte as Chief Executive Officer
Jul 7, 2015 08:00 AM Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery
Jul 2, 2015 04:30 PM Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets
Jul 2, 2015 09:30 AM Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D
Jul 2, 2015 03:00 AM ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries
Jun 25, 2015 11:20 AM Joseph J. Echevarria Elected To Pfizer’s Board Of Directors
Jun 25, 2015 11:15 AM Pfizer Declares 28-Cent Third-Quarter 2015 Dividend
Jun 24, 2015 01:19 PM CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age
Jun 23, 2015 02:15 PM GlycoMimetics to Receive $20 Million Payment from Pfizer Following Initiation of Phase 3 Trial with Rivipansel
Jun 23, 2015 02:00 PM Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease
Jun 23, 2015 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts
Jun 23, 2015 08:00 AM New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support
Jun 22, 2015 08:45 AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
Jun 22, 2015 08:45 AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
Jun 22, 2015 07:00 AM Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline
Jun 15, 2015 08:00 AM Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China
Jun 11, 2015 03:00 PM Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
Jun 10, 2015 08:00 AM Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015)
Jun 8, 2015 11:00 AM Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology
Jun 4, 2015 09:00 AM Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign
May 30, 2015 07:30 AM Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy
May 29, 2015 08:30 AM Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease
May 28, 2015 08:30 AM Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
May 28, 2015 08:00 AM Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health
May 26, 2015 09:00 AM ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV
May 19, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations
May 14, 2015 12:27 PM Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira
May 14, 2015 08:07 AM Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors
May 13, 2015 05:01 PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
May 11, 2015 04:30 PM Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
May 6, 2015 12:48 PM Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat
May 6, 2015 08:00 AM Nodality Launches PathPro™ T Cell Receptor (TCR) and B Cell Receptor (BCR) Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells
May 6, 2015 04:51 AM ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
Apr 28, 2015 07:30 AM Hospira Reports First-Quarter 2015 Results
Apr 28, 2015 07:00 AM PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
Apr 27, 2015 09:00 AM China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer
Apr 23, 2015 02:07 PM Pfizer Hosts Annual Meeting Of Shareholders
Apr 21, 2015 10:00 AM Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
Apr 21, 2015 08:00 AM Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Apr 21, 2015 08:00 AM Nodality Publishes Study Results Confirming the Company’s Diagnostic Can Predict Induction Therapy Response in Elderly Patients with Acute Myeloid Leukemia
Apr 20, 2015 08:00 AM Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
Apr 16, 2015 02:26 PM Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders
Apr 16, 2015 08:30 AM Pfizer Launches 2014 Integrated Annual Review
Apr 15, 2015 08:00 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine The
Pages: 1 2 »» Last Page

Back to PFE Stock Lookup